Skip to main content
Gujarat Ambuja Exports Ltd. logo

Gujarat Ambuja Exports Ltd. — Investor Relations & Filings

Ticker · GAEL ISIN · INE036B01030 LEI · 335800M9TVMR5FIXZ129 BSE.NS Manufacturing
Open in API
Filings indexed 966 across all filing types
Latest filing 2020-05-25 Annual Report
Country IN India
Listing BSE.NS GAEL

About Gujarat Ambuja Exports Ltd.

https://www.ambujagroup.com

Gujarat Ambuja Exports Ltd. is an agro-processing organization specializing in the manufacturing of corn-based starch derivatives, soy products, and cotton yarn. The company operates integrated processing facilities to produce liquid glucose, sorbitol, maltodextrin, and dextrose monohydrate, serving the food, pharmaceutical, and paper sectors. Its soy division focuses on de-oiled cakes, refined soy oil, and lecithin for the animal feed and human nutrition markets. GAEL maintains an extensive global export footprint, providing high-volume industrial ingredients that meet international quality standards. The company leverages large-scale production capabilities to supply diverse applications in the textile and healthcare industries, emphasizing efficiency and consistency across its product portfolio.

Recent filings

Filing Released Lang Actions
Updates
Annual Report Classification · 95% confidence The document contains detailed financial data including audited standalone and consolidated financial results for the quarter and year ended March 31, 2020. It references compliance with SEBI regulations and includes comprehensive income, profit/loss, tax details, and earnings per share. The length is substantial (15,000 characters) and the content is the actual financial results, not just an announcement or a certification. Therefore, this is a full Annual Report or equivalent official yearly financial report. The best matching category is Annual Report (10-K). FY 2020
2020-05-25 English
Financial Result Updates
Regulatory Filings
2020-05-23 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed summary of the proceedings of a Board of Directors meeting held on 23rd May 2020. It includes approval of audited financial results for the year ended 31st March 2020, re-appointments of independent directors, and appointments of auditors. The document contains detailed profiles of directors and auditors, indicating it is a formal disclosure to stock exchanges. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulations 30 and 33, which relate to disclosure of material events and financial results. The document is not the full annual report or financial statements themselves but a board meeting summary and related disclosures. It is not a certification or a short announcement but a comprehensive board meeting summary with multiple agenda items including financial results approval and director appointments. Therefore, it fits best under Board/Management Information (MANG) as it announces board decisions and management changes rather than being the full annual report or audit report.
2020-05-23 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document contains only image placeholders and no textual content or financial data. It is extremely short (221 characters) and does not provide any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2020-05-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate related to Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. It confirms that no dematerialization requests were received during the specified period (1st April 2020 to 30th April 2020). The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It is short (3109 characters) and serves as a formal attestation to the stock exchanges. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and does not contain financial statements or detailed financial data.
2020-05-04 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-04-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.